- Home
- Equipment
- north america
- cancer detection technologies
Refine by
Cancer Detection Technologies Equipment Supplied In North America
8 equipment items found
Manufactured by:Grail, Inc. based inMenlo Park, CALIFORNIA (USA)
GRAIL is poised to detect cancer early by combining high-intensity sequencing of unprecedented breadth and depth with the techniques of modern data science. Through what we believe to be one of the largest clinical study programs ever pursued in genomic medicine, GRAIL is creating vast datasets to develop evidence supporting our ...
by:VisionGate, Inc based inPhoenix, ARIZONA (USA)
Smart, Accurate, & Dynamic. Our AI Learns about Your Cells Fast. In addition to three dimensional images of your cells, our technology has the ability to learn and adapt to discover which cells should raise a red flag of warning and which are completely normal in your ...
Manufactured by:Avelas Biosciences based inLa Jolla, CALIFORNIA (USA)
Avelas’ Intraoperative Imaging Device simultaneously images two far red and near infra-red wavelengths to realize the advantages of ratiometric fluorescent readout of pegloprastide for real-time cancer ...
Manufactured by:Nucleix Ltd. based inSan Diego, CALIFORNIA (USA)
Lung cancer remains a leading cause of death from cancer globally, due to its high incidence and late-stage diagnosis. Most patients are currently diagnosed with late-stage cancer, though research has shown 5-year survival rates are up to 10 times greater when disease is detected early. Annual imaging (low-dose CT scans) is recommended for screening individuals with highest risk, but less than ...
Manufactured by:miR Scientific, LLC based inNew York, NEW YORK (USA)
The science behind miR’s prostate and bladder cancer detection and classification technology that can help give healthcare providers, patients, and payors the greatest confidence in test results and care ...
Manufactured by:Avelas Biosciences based inLa Jolla, CALIFORNIA (USA)
Pegloprastide (AVB-620) is based on the science of activatable cell-penetrating peptides and is designed to deliver a fluorescent marker specifically to cancer cells to enable surgeons to identify cancerous tissue in real-time and thus, avoid repeat surgeries and improve patient outcomes. Pegloprastide is the only fluorescence-based clinical cancer detection product that uses the ratio of two ...
Manufactured by:Guided Therapeutics, Inc. based inPeachtree Corners, GEORGIA (US) (USA)
Our patented technology, which features our flagship product the LuViva® Advanced Cervical Scan, uses biophotonics to detect both physical and chemical changes in tissues that are early signs of cancer. ...
Manufactured by:BioMark Diagnostics Inc. based inRichmond, BRITISH COLUMBIA (CANADA)
BioMark’s initial liquid biopsy assay detects SSAT1 using an FDA approved drug. SSAT1 is an enzyme with elevated levels in numerous cancers. The assay targets a well researched and understood metabolic pathway. BioMark of a few unique companies using safe therapeutic agents for diagnostic indication. As a non-invasive cost effective red alert tool, it is valuable to physicians around the ...